The PAM2 domain (amino acids 920-932) has been deleted from Hsap\ATXN2 in Hsap\ATXN232Q.UAS.
Hsap\ATXN232Q.ΔPAM2.UAS.Tag:MYC, Scer\GAL4GMR.PU is a non-enhancer of visible phenotype of Hsap\TARDBPUAS.cEa, Scer\GAL4GMR.PU
Hsap\ATXN232Q.ΔPAM2.UAS.Tag:MYC, Scer\GAL4elav.PLu is a non-enhancer of short lived phenotype of Hsap\TARDBPUAS.cEa, Scer\GAL4elav.PLu
Hsap\ATXN232Q.ΔPAM2.UAS.Tag:MYC, Scer\GAL4elav.Switch.PO is a non-enhancer of abnormal locomotor behavior | adult stage | RU486 conditional phenotype of Hsap\TARDBPUAS.cEa, Scer\GAL4elav.Switch.PO
Hsap\ATXN232Q.ΔPAM2.UAS.Tag:MYC, Scer\GAL4GMR.PU is a non-enhancer of eye phenotype of Hsap\TARDBPUAS.cEa, Scer\GAL4GMR.PU
Expression of Hsap\ATXN232Q.ΔPAM2.Scer\UAS.T:Hsap\MYC does not enhance the eye phenotype seen when Hsap\TARDBPScer\UAS.cEa is expressed under the control of Scer\GAL4GMR.PU. The reduction in lifespan induced by the expression of Hsap\TARDBPScer\UAS.cEa (under the control of Scer\GAL4elav.PLu) and climbing defects (under the control of Scer\GAL4elav.Switch.PO and raised with RU486) are also not enhanced.
Co-expression of pAbpScer\UAS.cSa and Hsap\ATXN232Q.ΔPAM2.Scer\UAS.T:Hsap\MYC under the control of Scer\GAL4GMR.PU does not induce retinal degeneration.